Trial intelligence / Profile preview

Intranasal oxytocin and social cognition in healthy young and older adults

ACTRN12618001343291Phase 3Recruiting

Sponsor
Australian Catholic University
Start
Jul 2016
Modality
Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 3, randomised trial of oxytocin (2 arms), sponsored by Australian Catholic University. Primary endpoint: Emotion Recognition Task performance. Started Jul 2016; status: recruiting.

02

Drugs

oxytocin

Beyond the preview

Go deeper on ACTRN12618001343291.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12618001343291.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call